Skip to main content
Medicus Pharma Ltd. logo

Medicus Pharma Ltd. — Investor Relations & Filings

Ticker · MDCX LEI · 984500563DE3E9558204 US Manufacturing
Filings indexed 262 across all filing types
Latest filing 2025-11-14 Regulatory Filings
Country CA Canada
Listing US MDCX

About Medicus Pharma Ltd.

https://medicuspharma.com/

Medicus Pharma Ltd. is a biotechnology and life sciences company focused on accelerating the clinical development of novel and disruptive therapeutic assets. The company's primary focus is on developing non-invasive treatments for dermatological conditions, specifically non-melanoma skin cancers. Its lead therapeutic candidate, SKNJCT-003, is being developed by its subsidiary, SkinJect Inc., for the treatment of basal cell carcinoma (BCC). The candidate is currently in Phase 2 clinical studies. Medicus Pharma aims to deliver improved treatment outcomes through the development of first-in-class and best-in-class therapies.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2025-11-14 English
FORM S-8
Registration Form
2025-11-14 English
FORM 10-Q
Interim / Quarterly Report Q3 2025
2025-11-14 English
FORM 424B3
Prospectus
2025-10-17 English
FORM 424B3
Prospectus
2025-10-17 English
FORM 253G2
Regulatory Filings
2025-10-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.